Dupixent\u00ae (dupilumab) Demonstrated Superiority Over Xolair\u00ae (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (

Posted Jun 15 by Two Blokes

New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary and secondary efficacy

Source: Two Blokes Trading

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in

Posted Jun 15 by Two Blokes

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps

Source: Two Blokes Trading

CAR FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Avis Budget Group, Inc. Investors with Losses in Excess of $100K

Posted Jun 15 by Two Blokes

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds pu

Source: Two Blokes Trading

NPWR Deadline: Rosen Law Firm Urges NET Power, Inc. (NYSE: NPWR) Stockholders with Losses in Excess of $100K to Contact the Firm

Posted Jun 15 by Two Blokes

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareho

Source: Two Blokes Trading

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important

Posted Jun 15 by Two Blokes

NEW YORK CITY, NY / ACCESS Newswire / June 15, 2025 / WHY: New York, N.Y., June 15, 2025.

Source: Two Blokes Trading

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Krispy Kreme, Inc. Investors to Secure Counsel Before Important Deadline i

Posted Jun 15 by Two Blokes

NEW YORK CITY, NY / ACCESS Newswire / June 15, 2025 / WHY: New York, N.Y., June 15, 2025.

Source: Two Blokes Trading

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Sec

Posted Jun 15 by Two Blokes

NEW YORK, NY / ACCESS Newswire / June 15, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, remin

Source: Two Blokes Trading

ROSEN, LEADING INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Secur

Posted Jun 15 by Two Blokes

NEW YORK CITY, NY / ACCESS Newswire / June 15, 2025 / WHY: New York, N.Y., June 15, 2025.

Source: Two Blokes Trading

ROSEN, A LEADING LAW FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Acti

Posted Jun 15 by Two Blokes

NEW YORK CITY, NY / ACCESS Newswire / June 15, 2025 / WHY: New York, N.Y., June 15, 2025.

Source: Two Blokes Trading

Securities Class Action Lawsuit Filed Against Compass Group Diversified Holdings, LLC (CODI) - Levi & Korsinsky Represents Share

Posted Jun 15 by Two Blokes

NEW YORK, NY / ACCESS Newswire / June 15, 2025 / If you suffered a loss on your Compass Group Diversified Hold

Source: Two Blokes Trading

Dupixent\u00ae (dupilumab) Demonstrated Superiority Over Xolair\u00ae (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (

Posted Jun 15 by Two Blokes

New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary and secondary efficacy

Source: Two Blokes Trading

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in

Posted Jun 15 by Two Blokes

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps

Source: Two Blokes Trading